Paragon 28 Inc (NYSE:FNA)
$ 10.35 0.08 (0.78%) Market Cap: 866.51 Mil Enterprise Value: 931.28 Mil PE Ratio: 0 PB Ratio: 6.20 GF Score: 57/100

Paragon 28 Inc at JPMorgan Healthcare Conference Transcript

Jan 08, 2024 / 11:00PM GMT
Release Date Price: $11.56 (-11.62%)
Lisa Cohen J.P. Morgan Securities LLC;Analyst

Good afternoon, everyone, and welcome to the 42nd Annual J.P. Morgan Healthcare Conference. My name is Lisa Cohen. I am a Vice President in San Francisco, and I sit in the healthcare investment banking group. Very excited to introduce our next company, Paragon. With me here today are Albert DaCosta, CEO, and Steve Deitsch, CFO. So with that, I will pass it on to them.

Albert DaCosta Paragon 28 Inc.;Chairman of the Board
President & CEO

Thank you. All right.

Thank you. Thanks for having us. It's great to see everybody here. I'm going to warn you ahead of time. That I might have a little bit of a coughing fit. If I do, I'm going to pass it over to Steve. Let's get started.

First thing, the story might be new for some of the folks here on. One thing I'd like to start off with is just kind of explaining a little bit about the foot and ankle market and that image there doesn't show any of the soft tissue structures. But if you think about from a skeletal perspective, the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot